Novartis AG

History

Year	Detail
1758	Johann Rudolf Geigy-Gemuseus has founded J.R. Geigy, a trading company to deal with chemicals, materials, drugs, and dyes in Basel, Switzerland.
1859	Alexander Clavel have started the production of fuchsine, a synthetic dye in his silk dyeing factory in Switzerland.
1886	Dr. Alfred Kern and Edouard Sandoz has founded the Kern & Sandoz, a chemical company in Basel, Switzerland.
1900	Ciba has started the production of its first pharmaceutical substances: Vioform and Salen, an antiseptic and antirheumatic agent.
1917	Prof. Arthur Stoll has developed a pharmaceutical department to start his research at Sandoz.
1970	Geigy and CIBA has been merged together to form CIBA-GEIGY.
1996	The merger between Sandoz and Ciba-Geigy formed Novartis AG.
2002	Novartis AG unifies and strengthens its global research network by founding the Novartis Institutes for BioMedical Research (NIBR) in the U.S.
2019	Alcon becomes a standalone trading company while Novartis AG strengthens its focus towards geenric and advanced medicines.